After 5 vaccinations, the remaining amount can be used… “Helps to eliminate supply shortages”
–
[로이터=연합뉴스 자료사진]
–
(Seoul = Yonhap News) Reporter Kim Bum-soo = It is reported that the US Food and Drug Administration (FDA) has set guidelines so that the remaining parts of the vaccine bottle can be used as a measure to resolve the shortage of vaccine supply for the novel coronavirus infection (Corona 19).
Politico reported that the Food and Drug Administration (FDA) made it possible to use the remainder of the Corona 19 vaccine bottle late in the afternoon on the 16th (local time).
An FDA official told Politico, “Considering that it is an emergency with respect to public health, we have made it possible to use all the quantities contained in the vaccine bottle.”
The media reported that Pfizer, a vaccine developer, received such guidelines late this afternoon.
This could lead to an increase in the supply of vaccines, which are in short supply, by up to 40%, the media said.
The Pfizer vaccine, which started on the 14th across the United States, officially contains five doses per bottle.
However, as a result of checking at a front-line pharmacy, it was found that 6 to 7 doses of vaccine were contained per bottle. Therefore, it is said that the use of the remaining vaccine will be of great help in resolving the supply-demand imbalance.
In practice, pharmaceutical companies inject a sufficient amount of the vaccine bottle to exceed the threshold for possible spills or spills during the vaccination process.
After the vaccination began, pharmacies disposed of the vaccine bottle with the remaining amount in accordance with the regulations of the authorities that the remaining amount should not be used after the 5 doses.
No new guidelines were issued at the federal level. This is a confused atmosphere at the front line pharmacies.
“Pharmacies in Utah were only advised to comply with the FDA’s emergency use guidelines, which require only five doses per bottle,” said Erin Fox of the University of Utah.
Meanwhile, the U.S. FDA and Pfizer are banning this because the vaccine can be contaminated if the residuals from different bottles are mixed.
Sharon Castillo, Pfizer’s public relations officer, said, “It is difficult to state at the moment on the treatment of the remaining amount.”
<저작권자(c) 연합뉴스,
Unauthorized reproduction-redistribution prohibited>
2020/12/17 11:29 sent
–
